These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Do not repeat mistakes from HIV in COVID-19 response. The Lancet Hiv Lancet HIV; 2021 Feb; 8(2):e59. PubMed ID: 33493437 [No Abstract] [Full Text] [Related]
24. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question. Marjot T; Webb GJ; Barritt AS; Ginès P; Lohse AW; Moon AM; Pose E; Trivedi P; Barnes E Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):156-158. PubMed ID: 33444545 [No Abstract] [Full Text] [Related]
25. SARS-CoV-2 vaccination and phase 1 cancer clinical trials. Yap TA; Siu LL; Calvo E; Lolkema MP; LoRusso PM; Soria JC; Plummer R; de Bono JS; Tabernero J; Banerji U Lancet Oncol; 2021 Mar; 22(3):298-301. PubMed ID: 33571468 [No Abstract] [Full Text] [Related]
26. Immunity to glycan α-Gal and possibilities for the control of COVID-19. la Fuente J; Gortázar C; Cabezas-Cruz A Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805 [No Abstract] [Full Text] [Related]
27. SARS-CoV-2: vaccines in the pandemic era. Li DD; Li QH Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220 [TBL] [Abstract][Full Text] [Related]
28. Vaccine-induced protection in aging adults and pandemic response. Schenkelberg T Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845 [No Abstract] [Full Text] [Related]
29. Leave no one behind: ensuring access to COVID-19 vaccines for refugee and displaced populations. Zard M; Lau LS; Bowser DM; Fouad FM; Lucumí DI; Samari G; Harker A; Shepard DS; Zeng W; Moresky RT; Audi MN; Greene CM; Kachur SP Nat Med; 2021 May; 27(5):747-749. PubMed ID: 33875889 [TBL] [Abstract][Full Text] [Related]
30. The UK has approved a COVID vaccine - here's what scientists now want to know. Ledford H; Cyranoski D; Van Noorden R Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887 [No Abstract] [Full Text] [Related]
31. COVID-19 vaccination: the VOICE for patients with cancer. van der Veldt AAM; Oosting SF; Dingemans AC; Fehrmann RSN; GeurtsvanKessel C; Jalving M; Rimmelzwaan GF; Kvistborg P; Blank CU; Smit EF; Lemmens VEEP; Hiltermann TJN; Koopmans MPG; Huckriede ALW; Rots NY; van Els CACM; van Baarle D; Haanen JBAG; de Vries EGE Nat Med; 2021 Apr; 27(4):568-569. PubMed ID: 33589821 [No Abstract] [Full Text] [Related]
32. Current advances in the development of SARS-CoV-2 vaccines. Awadasseid A; Wu Y; Tanaka Y; Zhang W Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829 [TBL] [Abstract][Full Text] [Related]
33. Editorial: Challenges in Vaccinology. Lavelle EC; Carsetti R; Pickl WF; Wiedermann U Front Immunol; 2020; 11():632537. PubMed ID: 33391292 [No Abstract] [Full Text] [Related]
34. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates. Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318 [TBL] [Abstract][Full Text] [Related]
35. COVID-19 vaccines for patients with haematological conditions. Sun C; Pleyer C; Wiestner A Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822 [No Abstract] [Full Text] [Related]
36. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Sharma O; Sultan AA; Ding H; Triggle CR Front Immunol; 2020; 11():585354. PubMed ID: 33163000 [TBL] [Abstract][Full Text] [Related]